^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in Ringer’s injection, lactated.

^d Test performed using the formulation WITHOUT edetate disodium.

^e Ampicillin component. Ampicillin in a 2:1 fixed-ratio concentration with sulbactam.

^f Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

^g Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.

^h Not specified whether concentration refers to single component or combined components.

ⁱ Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^j Presence or absence of edetate disodium not specified.

^k Tested in both dextrose 5% and sodium chloride 0.9%.

^l Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^m Test performed using the formulation WITH edetate disodium.

ⁿ Salt not specified.

^o Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^p Subvisible particulate test methods include light obscuration, flow imaging microscopy, and backgrounded membrane imaging.

^q Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^r Intralipid product.

^s SMOFlipid product.